Publikace
- Valganciclovir versus valacyclovir prophylaxis for prevention of cytomegalovirus: an economic perspective2015 | Lékařská fakulta v Plzni
- A Randomized Trial of Valganciclovir Prophylaxis Versus Preemptive Therapy in Kidney Transplant Recipients2023 | Lékařská fakulta v Plzni
- Safety and efficacy of one and two booster doses of SARS-CoV-2 mRNA vaccines in kidney transplant recipients: A randomized clinical trial2023 | Lékařská fakulta v Plzni
- Insufficient response to mRNA SARS-CoV-2 vaccine and high incidence of severe COVID-19 in kidney transplant recipients during pandemic2022 | Lékařská fakulta v Plzni
- Cytomegalovirus prevention strategies and the risk of BK polyomavirus viremia and nephropathy2019 | Lékařská fakulta v Plzni
- Viral load and duration of BK polyomavirus viraemia determine renal graft fibrosis progression: histologic evaluation of late protocol biopsies2019 | Lékařská fakulta v Plzni
- BK polyomavirus and valganciclovir: Highly suspected association urgently calling for a new randomized trial2019 | Lékařská fakulta v Plzni
- Less renal allograft fibrosis with valganciclovir prophylaxis for cytomegalovirus compared to high-dose valacyclovir: a parallel group, open-label, randomized controlled trial2018 | Lékařská fakulta v Plzni
- The impact of viral load and time to onset of cytomegalovirus replication on long-term graft survival after kidney transplantation2017 | Lékařská fakulta v Plzni
- Budoucnost farmakoterapie v nefrologii2015 | 1. lékařská fakulta, Lékařská fakulta v Plzni, 3. lékařská fakulta, Lékařská fakulta v Hradci Králové
Loading network view...